Knowledge gap about immune checkpoint inhibitors among rheumatologists and medical students: a survey
| Autor: | Lucas Teixeira Dos Santos Brasil, Morton Aaron Scheinberg, Joaquim Ivo Vasques Dantas Landim, Guilherme Ferreira Maciel Da Silva, Isabella Cabral Marinho Plens, Francisco Airton Castro Rocha, Andressa Laura Castro Silva |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Male
medicine.medical_specialty 2019-20 coronavirus outbreak Health Knowledge Attitudes Practice Students Medical Immune checkpoint inhibitors Immunology 03 medical and health sciences 0302 clinical medicine Continuing medical education Rheumatology Internal medicine Surveys and Questionnaires Immunology and Allergy Medicine Humans 030212 general & internal medicine Immune Checkpoint Inhibitors 030203 arthritis & rheumatology business.industry Medical practice Cancer treatment Private practice Family medicine Female business Developed country Brazil |
| Zdroj: | Rheumatology international. 41(5) |
| ISSN: | 1437-160X |
| Popis: | Previous studies found that physicians working in developed countries in Europe and in the USA declared insufficient knowledge concerning immune-related adverse events (irAE) following use of immune checkpoint inhibitors (ICI) in cancer treatment. We determined this knowledge gap among rheumatologists and medical students (MS) in Brazil. A web-based structured survey or a direct interview was applied to 1428 board-certified Brazilian rheumatologists and an adapted questionnaire was sent to 840 undergraduate MS attending the last 2 years of Medical Schools in Fortaleza-CE, Brazil, in September 2019. 228 (15.9%) rheumatologists and 145 (17.2%) MS answered the survey; 136 (60%) rheumatologists worked at Institutions with Oncology service. Rheumatologists had 22.6 ± 12.6 years of medical practice, most [116 (50.9%)] worked in private practice and 9 (3.9%) were on training. Fifty-three (23.4%) declared being familiar [40 (17.6%)] or very familiar [13 (5.8%)] with irAE. Almost two-thirds declared having never managed irAE and about a third (38.6%) felt confident in managing such patients. Knowledge among rheumatologists was similar regardless of having more or less than 10 years of practice (P = 0.758). Less than 5% MS declared being familiar with ICI and most have never heard of irAE. There is a large gap concerning knowledge about ICI and irAE among rheumatologists and MS in Brazil. Continuing medical education strategies are needed to improve this knowledge. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink